Abstract
Efficient and controllable expression of a transgene usually requires the presence of intron sequences and much efforts have been made to produce retrovirus vectors that can transduce and integrate genes with introns. However, this has proven difficult because the viral RNA is spliced when it is synthesized in the nucleus of a producer cell. We describe a novel approach to avoid this problem. In our system the retroviral RNA is synthesized in the cytoplasm of the cell, not in the nucleus, in a reaction driven by the Semliki Forest virus (SFV) expression system. The approach was tested with a recombinant Moloney murine leukemia virus genome containing the chloramphenicol acetyltransferase (CAT) gene in association with an intron. This was inserted into a SFV transcription plasmid and the corresponding SFV vector RNA was transcribed in vitro. BHK-21 cells were then transfected with this vector RNA together with two additional SFV vectors that encode the Moloney murine leukemia virus packaging proteins. Retrovirus vectors containing intron-CAT sequences were produced at titers up to 1.3 × 106 infectious particles per ml during a 5-hr incubation period. The vectors faithfully transduced the intron-containing CAT gene into NIH 3T3 cells, where the intron-CAT RNA was subjected to efficient splicing and used for high level enzyme expression. Thus, the results show that intron containing genes can be efficiently packaged into retrovirus vectors by the SFV expression system.
Vectors based on retroviruses have established themselves as useful tools for stable gene transfer into animal cells both in vitro and in vivo (1, 2). These RNA viruses carry a reverse transcriptase, which converts their genome into double-stranded DNA and further an integrase, which catalyses the insertion of the genome into the DNA of host chromosomes (3). The integrated viral genome, or provirus, is copied by transcription into RNA molecules that are transported into the cytoplasm and then encapsidated into virus particles. When used as vectors, the proviral DNA is engineered and transfected into packaging cells (4). These cells provide all retroviral structural proteins and enzymes in trans. One major drawback with the retrovirus vector system is that it is in practice limited to transduce cDNA forms of processed mRNAs. These minigenes lack important control elements that sometimes leads to disappointingly low expression levels (5–7). In particular, it is difficult to use the retrovirus vector system for transduction of genes with intervening sequences (introns). The reason is that any intron present in an engineered provirus will be removed from the RNA form of the viral genome by the nuclear splicing machinery (8, 9). Here we describe a novel strategy to package intron containing genes into retroviruses. This is based on the transient expression of the RNA form of the viral genome directly in the cytoplasm of the cells using an alphavirus RNA vector.
MATERIALS AND METHODS
Cell Culture.
Baby hamster kidney (BHK)-21 cells (American Type Culture Collection, Rockville, MD) were cultured in BHK-21 medium (GIBCO) containing 5% fetal calf serum, 10% tryptose phosphate broth, 20 mM Hepes, and 2 mM glutamine. NIH 3T3 cells were cultured in DMEM (GIBCO) supplemented with 10% fetal calf serum, 4,500 mg/l glucose, and 2 mM glutamine. HeLa cells were cultured in MEM alpha medium (GIBCO) supplemented with 10% fetal calf serum.
Plasmid Constructs.
The maps of pSFV1-I-CAT and pSFV1-CAT constructs are shown in Fig. 1. A BglII-BamHI fragment containing the simian virus 40 (SV40) early promoter, a chimeric intron, the CAT gene, and the SV40 late poly(A) signal was excised from pCAT-promoter vector (Promega) and inserted into the pSFV1/LN3i (10) downstream of the neoR gene by subcloning to make pSFV1-I-CAT. To make the intron-free pSFV1-CAT we first removed the intron from the pCAT-promoter vector with HindIII and then proceeded as described for the pSFV1-I-CAT construction.
Production of Retroviral Vectors.
The plasmid DNA was linearized with NruI and used as template for RNA synthesis in vitro by SP6 polymerase. The RNA was introduced into BHK-21 cells together with SFV-C/gag-pol RNA and SFV1/Pr80env RNA or SFV1/AMenv RNA (10) by electroporation. The transfected BHK-21 cells were diluted into complete BHK medium and plated onto a 60-mm culture dish (Nunclon, Naperville, IL). The cells were incubated at 37°C for 5 hr, and then the media were replaced with 2 ml aliquots of fresh complete BHK-medium. After 5 hr incubation, the media were collected, passed through a 0.45 μm filter, and stored at −130°C. NeoR-transduction-competent retrovirus particles were titrated on NIH 3T3 cells as described (10).
CAT Assay.
The CAT gene expression was measured by the CAT enzyme assay system with reporter lysis buffer (Promega) according to the instructions of the manufacturer. In brief, the cells were lysed by addition of 400 μl of 1× lysis buffer into each dish and incubated at room temperature for 15 min. The lysates were then heated at 60°C for 10 min. An aliquot of each lysate (100 μl) was mixed with 3 μl of [14C]-labeled chloramphenicol (0.05 mCi/ml, DuPont/NEN; 1 Ci = 37 GBq), 5 μl of n-butyryl CoA (5 mg/ml), and 17 μl of H2O and incubated at 37°C for 16 hr. The reaction was terminated by addition of 300 μl of xylenes (Aldrich) followed by mixing. The upper xylene phase was removed and back-extracted twice with 0.25 M Tris⋅HCl, pH 8.0. A portion of the xylene phase (200 μl) was mixed with 3 ml scintillation fluid and the radioactivity ([14C] cpm) measured in a liquid scintillation counter.
Provirus Analysis.
Proviruses were analyzed by PCR. DNA was isolated from cells with the TRIzol Reagent (GIBCO/BRL) and used in PCR together with the pfu DNA polymerase (Stratagene). The DNA was first denatured at 95°C for 5 min. The PCR reaction was then carried out at 94°C for 45 sec, 65°C for 45 sec, and 72°C for 3 min and repeated in 30 cycles. The two primers used to detect the provirus were primer 1 (5′-GAAGAGCTTGGCGGCGAATG-3′) and primer 2 (5′-TATCGAACCCCAGAGTCCGT-3′). The upstream primer 1 hybridizes to the 3′ region of the neoR gene and the downstream primer 2 to a region just downstream of the SV40 fragment carrying the poly(A) signal (Fig. 3 A and B). The PCR products were analyzed on a 0.7% agarose gel.
Analysis of CAT Gene Transcription.
Transcription of CAT genes was analyzed by reverse transcription (RT)–PCR. Total RNA were isolated from cells with the TRIzol Reagent and used in RT-PCR according to the Access RT-PCR System (Promega). The first strand DNA was synthesized by avian myoblastosis virus reverse transcriptase at 48°C for 45 min. Next, the RNA/DNA hybrids were denatured and the avian myoblastosis virus reverse transcriptase was inactivated by incubation at 94°C for 2 min. Second strand DNA synthesis and DNA amplification were done by TfI DNA polymerase. The DNA amplification was carried out at 94°C for 45 sec, 65°C for 45 sec, and 68°C for 3 min and repeated in 45 cycles. The primers used for RT-PCR were primer 1, primer 2, primer 3 (5′-TGCAGAAGTTGGTCGTGAGG-3′) and primer 4 (5′-TAGTGAGGAGGCTTTTTTGG-3′). Primer 3 hybridizes to a region just in front of the 5′ splice site of the CAT-associated intron and primer 4 to a region just downstream of the SV40 promoter (Fig. 3 C–F). The RT-PCR products were analyzed on a 0.7% agarose gels.
RESULTS
Efficient Production of Retroviral Vectors with Intron-Containing CAT Genes.
We have shown previously that SFV-derived RNA vectors can be used to synthesize recombinant RNA genomes of the Moloney murine leukemia virus (Mo-MuLV) in the cytoplasm of the cell and that these genomes can be packaged into transduction competent retrovirus particles (10). In these experiments the Mo-MuLV proteins were coexpressed from two additional SFV RNA vectors. We reasoned that the cytoplasmic SFV expression system should also facilitate an uncompromised production of Mo-MuLV vectors with intron-containing genes. To test this possibility we constructed two new SFV vector plasmids (Fig. 1A). These were designed to express a recombinant Mo-MuLV RNA genome containing a CAT gene with and without an intron (pSFV1-I-CAT and pSFV1-CAT). In both constructs the CAT gene is preceded by an internal promoter and followed by an internal poly(A) signal, both derived from SV40. In addition the constructs contain the neoR gene, under the control of the Mo-MuLV promoter, in their 5′ long-terminal repeats (LTRs). The corresponding SFV RNA vectors were transcribed in vitro and used for transfection of BHK-21 cells together with the SFV RNA vectors that specified expression of the Mo-MuLV gagpol and env precursor proteins. We used both the ecotropic and the amphotropic env gene in the coexpression experiments. Media from cotransfected cells, collected between 5–10 hr after electroporation, were analyzed for neoR transducing vectors on NIH 3T3 cells. The titers ranged from 3.4 × 105 to 7.6 × 106 colony-forming units/ml (Fig. 1B). This shows that neoR-transduction competent retroviral vectors were formed efficiently in the transfected BHK-21 cells.
High CAT Expression in Cells Infected with Vectors Carrying a CAT Gene with an Intron.
NIH 3T3 cells that have been infected with ecotropic vectors were used to measure CAT activity. This was done with cells that had been selected in G418 medium for neoR expression as well as in unselected cells that had been incubated for only two days after infection. Fig. 2A shows the CAT activity in unselected cells. Lysates from cells infected with retroviral vectors from the SFV1-CAT RNA transfected BHK-21 cells contained very low CAT activity. In contrast, lysates from cells infected with retroviral vectors from SFV1-I-CAT RNA transfected BHK-21 cells had high CAT activity. Fig. 2B shows the corresponding analyses of cells that had been selected in G418 containing media for 6 days. Cells infected with the I-CAT vectors retained their high CAT activity whereas cells infected with the CAT vectors had lost most of their activity. Fig. 2C shows the CAT activity in nine G418-selected I-CAT and CAT cell clones, respectively. The activity of most I-CAT cell clones was high and that of all CAT clones barely above background level. We conclude that both vectors can transduce the internal CAT expression unit into the recipient cells in a functional form. However, only the intron-containing construct can promote a stable CAT expression at high level. Very similar CAT expression was found in HeLa cells infected with the amphotropic I-CAT and CAT vectors (data not shown). Altogether these data confirm the general notion that intron-containing genes are more efficiently expressed than genes lacking introns. Indeed, inefficient expression of CAT from a retrovirus vector containing a SV40 promoter-driven, CAT expression unit without introns has been observed before (11).
Intact Intron-Containing CAT Genes Are Packaged into Retroviral Vectors and Transferred into Recipient Cells.
The structures of the I-CAT and CAT genes in the transduced cell clones were studied by PCR. DNA was extracted from each of the cell clones of the two series and used as template for primers to the regions that were flanking the I-CAT and CAT expression units (primers 1 and 2 in Fig. 3 A and B). Polymerization reactions with DNA from the I-CAT and CAT cells should yield a single DNA fragment of 1,540 bp and 1,317 bp, respectively. Bands corresponding to the two fragments were seen when pSFV1-I-CAT and pSFV1-CAT plasmid DNAs were used as control templates (Fig. 3 A and B, “positive 1” and “positive 2,” respectively). The DNA analyses of the cell clones showed that the larger PCR fragment was generated in all reactions with DNA from I-CAT cells (Fig. 3A) and the smaller one in all reactions with DNA from CAT cells (Fig. 3B). In Fig. 3G, lanes 2 and 3, samples of reactions with DNA from I-CAT-1 and CAT-1 cells were run next to each other to clearly demonstrate the size difference between the two fragments. No distinct bands were found in gel analyses of PCR reactions done in the absence of DNA (Fig. 3B, “negative”) or with DNA extracted from untransduced NIH 3T3 cells (Fig. 3A, “NIH 3T3”). Thus, these results suggest that all I-CAT clones carry an intron-containing CAT expression unit whereas all CAT clones contain a CAT unit without intron. Additionally the data suggest that both units contain the SV40-derived poly(A) signal (pA in Fig. 1A). We conclude that we have been able to package an intron-containing gene efficiently into retrovirus vectors using the cytoplasmic expression system of SFV.
The CAT-Associated Intron Is Efficiently Removed by the Nuclear Splicing Machinery in Transduced Cells.
To find out how efficiently the nuclear splicing machinery can remove the CAT-associated intron from proviral transcripts, we analyzed the RNA of the I-CAT cell clones by RT-PCR. The CAT cell clones were analyzed in parallel as controls. The recombinant provirus is expected to drive RNA transcription both from the viral promoter in the 5′ LTR and from the internal SV40 promoter (Fig. 3, C–F, Upper). We first used primers 1 and 2 to follow the splicing of the intron in the LTR-derived transcript (Fig. 3C). These primers should generate a 1,540-bp fragment from the unspliced form of the transcript and a 1,407-bp fragment from the spliced one. A gel analyses of the reaction mixtures with RNA from the I-CAT clones showed, in each case, two closely migrating bands that corresponded to the expected fragments. This band doublet migrated between the 1,587-bp and 1,375-bp DNA markers and the position is indicated with an arrow in Fig. 3C. The two bands of the I-CAT-1 sample were more clearly shown in Fig. 3G, lane 4. The faster migrating band was more intense than the slower one in all samples. This suggested that most of the I-CAT RNA was present in a spliced form. The corresponding analyses of reactions with RNA extracted from CAT cell clones showed only one band, which corresponded to the expected 1,317-bp fragment (Fig. 3 D and G, lane 5).
Additional RNA analyses were done with two different upstream primers (primers 3 and 4). With primer 3, DNA polymerization is initiated just upstream of the CAT-associated intron. When this is used together with the downstream primer 2 and I-CAT RNA as the template, a 1,201-bp fragment should be generated from the unspliced, LTR- or SV40-driven transcripts and a 1,069-bp band from their spliced forms. The results in Fig. 3E and in Fig. 3G, lane 6, show the corresponding band doublet. The faster migrating band predominates, again suggesting that most of the transcripts have been subjected to RNA splicing in the cells. When RNA from CAT cells was subjected to RT-PCR with primer 3 and 2 no distinct products were generated (data not shown). This was expected as the template region for primer 3 is lacking in the CAT construct.
Primer 4 binds to a region that corresponds to the 5′ end of the SV40 transcript (Fig. 3F). This region is present in both the I-CAT and the CAT constructs. When the primers 4 and 2 were used with the I-CAT RNA in a RT-PCR reaction a band-doublet was seen as in the reaction with primer 3 and 2 (data not shown). This doublet corresponded to the fragments expected from the unspliced and spliced form of LTR- or SV40-driven transcripts. The reaction with RNA from the CAT clones yielded only a single band, which corresponded to the expected 1036-bp fragment (Fig. 3 F and G, lane 7). Thus, the RNA analyses with primers 3 and 4 confirmed the efficient splicing of the CAT-associated intron from proviral transcripts. This fact would, most likely, make it very difficult to produce I-CAT containing retrovirus vectors by the conventional procedure, where a provirus is used to transfect a packaging cell line.
It should be noted that the LTR transcripts also contain a splice donor and acceptor site in the ψ+ region (1). These, however, are known to mediate only inefficient splicing. Therefore we did not analyze their possible effects on the proviral RNA processing in the CAT and I-CAT cell clones.
DISCUSSION
There is today a large number of gene expression studies, both in tissue culture cells and in transgenic animals, which show that intron-containing genes are expressed more efficiently than intronless ones. The introns have been shown to influence gene expression in several ways. In general the presence of an intron in the pre-mRNA appears to stimulate accumulation of mRNA in the cytoplasm through its interaction with the nuclear splicing machinery (12–15). It has also been reported that the intervening sequences can increase 3′ processing of the mRNA (16). In other cases introns have been shown to contain enhancer elements that are required for differentiation-specific gene expression (17–20). Furthermore introns might facilitate packaging of genes into chromatin (21). Therefore much effort has been made to adapt the integrating retroviral gene-transduction systems to intron-containing genes. As earlier studies have already shown that intervening sequences of foreign genes are removed during synthesis and processing of viral RNA from engineered provirus, the general approach has been to introduce a complete foreign gene expression unit in reverse orientation into the provirus. Although this approach has resulted in successful transduction of some intron-containing genes, the experience today is that these vectors are often difficult to produce in packaging cells. The major reason seem to be that fortuitous RNA processing signals for splicing and polyadenylation are frequently found in the reversed sequence of the foreign gene (22–24). This is not surprising as the reversed stretch represent an unnatural sequence that has never been transcribed in a cell. Consequently the viral RNA may be prematurely terminated or rearranged with dysfunction of both the viral gene-transduction process and foreign gene expression as a result. Other potential problems with the reversed sequence approach are that the viral promoter and the reversed internal promoter in the engineered provirus compete for transcription and/or that the two different transcripts form a duplex through their complementary features (25, 26). Our present approach avoids all of these problems because our retroviral RNA transcription is driven by a cytoplasmic RNA expression system. This facilitates both the accumulation of unprocessed RNA directly in cytoplasm and its encapsidation into retroviral particles. In this work we have clearly demonstrated the feasibility of this approach by using the SFV expression system. With this, we have produced retrovirus vectors, containing an internal CAT expression unit, including a promoter, an intron and a poly(A) signal, at high titers (up to 1.3 × 106 colony-forming units/ml). It is obvious that the benefits of a cytoplasmic expression strategy to produce retroviral RNA constructions is not limited to intron-containing genes but also includes genes in complex with promoter or enhancer elements as well as locus control regions. Such regulatory regions mostly consist of untranscribed sequences and therefore suffer from the same problems of fortuitous splicing and polyadenylation as the reversed genes do in the conventional retrovirus packaging system (23, 27, 28).
Acknowledgments
We thank Mathilda Sjöberg for critically reading this manuscript. This work was supported by the Swedish Cancerfund Grant 3277-B94-03XAC, the Swedish Natural Science Research Council Grant B-AA/BU 09359-311 and the European Union Grant FMRX-CT96-0004.
Footnotes
This paper was submitted directly (Track II) to the Proceedings Office.
Abbreviations: CAT, chloramphenicol acetyltransferase; I-CAT, intron-containing CAT; SFV, Semliki Forest virus; Mo-MuLV, Moloney murine leukemia virus; LTR, long terminal repeat; RT, reverse transcription; BHK, baby hamster kidney; SV40, simian virus 40.
References
- 1.Miller A D, Rosman G J. BioTechniques. 1989;7:980–990. [PMC free article] [PubMed] [Google Scholar]
- 2.Hodgson C P, editor. Retro-Vectors for Human Gene Therapy. Heidelberg,: Springer; 1996. pp. 25–72. [Google Scholar]
- 3.Luciw P A, Leung N J. In: The Retroviridae. Levy J A, editor. Vol. 1. New York: Plenum; 1992. pp. 159–298. [Google Scholar]
- 4.Miller A D. Hum Gene Ther. 1990;1:5–14. doi: 10.1089/hum.1990.1.1-5. [DOI] [PubMed] [Google Scholar]
- 5.Grosveld F, van Assendelft G B, Greaves D R, Kollias G. Cell. 1987;51:975–985. doi: 10.1016/0092-8674(87)90584-8. [DOI] [PubMed] [Google Scholar]
- 6.Brinster R L, Allen J M, Behringer R R, Gelinas R E, Palmiter R D. Proc Natl Acad Sci USA. 1988;85:836–840. doi: 10.1073/pnas.85.3.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Buchman A R, Berg P. Mol Cell Biol. 1988;8:4395–4405. doi: 10.1128/mcb.8.10.4395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shimotohno K, Temin H M. Nature (London) 1982;299:265–268. doi: 10.1038/299265a0. [DOI] [PubMed] [Google Scholar]
- 9.Sorge J, Hughes S H. J Mol Appl Genet. 1982;1:547–559. [PubMed] [Google Scholar]
- 10.Li K-J, Garoff H. Proc Natl Acad Sci USA. 1996;93:11658–11663. doi: 10.1073/pnas.93.21.11658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Byun J, Kim S-H, Kim J M, Yu S S, Robbins P, Yim J, Kim S. Gene Ther. 1996;3:780–788. [PubMed] [Google Scholar]
- 12.Gruss P, Lai C-J, Dhar R, Khoury G. Proc Natl Acad Sci USA. 1979;76:4317–4321. doi: 10.1073/pnas.76.9.4317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chang D D, Sharp P A. Cell. 1989;59:789–795. doi: 10.1016/0092-8674(89)90602-8. [DOI] [PubMed] [Google Scholar]
- 14.Korb M, Ke M, Johnson L F. Nucleic Acids Res. 1993;21:5901–5908. doi: 10.1093/nar/21.25.5901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kurachi S, Hitomi Y, Furukawa M, Kurachi K. J Biol Chem. 1995;270:5276–5281. doi: 10.1074/jbc.270.10.5276. [DOI] [PubMed] [Google Scholar]
- 16.Huang M T F, Gorman C M. Nucleic Acids Res. 1990;18:937–947. doi: 10.1093/nar/18.4.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Konieczny S F, Emerson C P J. Mol Cell Biol. 1987;7:3065–3075. doi: 10.1128/mcb.7.9.3065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rossi P, de Crombrugghe B. Proc Natl Acad Sci USA. 1987;84:5590–5594. doi: 10.1073/pnas.84.16.5590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bender M A, Miller A D, Gelinas R E. Mol Cell Biol. 1988;8:1725–1735. doi: 10.1128/mcb.8.4.1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jonsson J J, Foresman M D, Wilson N, McIvor R S. Nucleic Acids Res. 1992;20:3191–3198. doi: 10.1093/nar/20.12.3191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Liu K, Sandgren E P, Palmiter R D, Stein A. Proc Natl Acad Sci USA. 1995;92:7724–7728. doi: 10.1073/pnas.92.17.7724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Miller A D, Bender M A, Harris E A S, Kaleko M, Gelinas R E. J Virol. 1988;62:4337–4345. doi: 10.1128/jvi.62.11.4337-4345.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Leboulch P, Huang G M S, Humphries R K, Oh Y H, Eaves C J, Tuan D Y H, London I M. EMBO J. 1994;13:3065–3076. doi: 10.1002/j.1460-2075.1994.tb06605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Jonsson J J, Habel D E, McIvor R S. Hum Gene Ther. 1995;6:611–623. doi: 10.1089/hum.1995.6.5-611. [DOI] [PubMed] [Google Scholar]
- 25.Cone R D, Reilly E B, Eisen H N, Mulligan R C. Science. 1987;236:954–957. doi: 10.1126/science.3107128. [DOI] [PubMed] [Google Scholar]
- 26.Karlsson S, Papayannopoulos T, Schweiger S G, Stamatoyannopoulos G, Nienhuis A W. Proc Natl Acad Sci USA. 1987;84:2411–2415. doi: 10.1073/pnas.84.8.2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chang J C, Liu D, Kan Y W. Proc Natl Acad Sci USA. 1992;89:3107–3110. doi: 10.1073/pnas.89.7.3107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.McIvor R S. Virology. 1990;176:652–655. doi: 10.1016/0042-6822(90)90039-t. [DOI] [PubMed] [Google Scholar]